Advertisement

Organisation › Details
Biogen (Switzerland) AG [OLD]
![]() |
Start | 1997-01-01 existent |
![]() |
End | 2011-05-01 liquidated |
Group | Biogen (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | Küsnacht ZH |
Country | Switzerland | |
City | 8700 Küsnacht ZH | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2025-03-16 |
Advertisement

More documents for Biogen (Group)
- [1] Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris....
- [2] Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA....
- [3] Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA....
- [4] Anjarium Biosciences AG. (7/12/22). "Press Release: Anjarium Biosciences Appoints Experienced Industry Executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer". Zurich....
- [5] MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA....
- [6] Cevec Pharmaceuticals GmbH. (1/8/21). "Press Release: Cevec Announces New License Agreement for Its AAV Manufacturing Technology Elevecta in Gene Therapy". Cologne....
- [7] ViGeneron GmbH. (1/5/21). "Press Release: ViGeneron Signs Global Collaboration Agreement for Ophthalmic Gene Therapy Development". Munich....
- [8] Merck KGaA. (12/11/20). "Press Release: Bavencio (avelumab) Receives Positive CHMP Opinion for First-line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma". Darmstadt....
- [9] Merck KGaA. (9/29/20). "Press Release: Press Release as a Result of the Ad-hoc Announcement of September 29, 2020". Darmstadt....
- [10] European Pharma Oligonucleotide Consortium (EPOC). (1/25/19). Web Site: European Pharma Oligonucleotide Consortium [incl. EPOC Presenation by Roche Orr, 8 November 2018, at EuroTides]. [www.epoconsortium.com, 01/25/19]...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top